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The association of reduced bone density with paraspinal muscle atrophy and adipose
tissue in geriatric patients: a cross-sectional CT study
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Background/aim: The aim of the study is to examine the relationship among bone density, adipose tissue, and muscle mass with
abdominal CT in geriatric patients.
Materials and methods: The study is a retrospective cohort study of patients 65 years and over who underwent abdominal CT for any
reason between October 2017 and July 2018. Third lumbar vertebra density, fatty degeneration of the paraspinal muscle, subcutaneous
adipose tissue, and mesenteric adipose tissue ratio were evaluated.
Results: A total of 312 patients, 144 females and 168 males, were included in the study. Reduced bone density was found in 237 (76%)
patients. Reduced bone density and muscle atrophy was more frequent in females (P < 0.001). Muscle atrophy was found to occur
5.7 times more frequently in cases of reduced bone density (OR, 95% CI = 5.74 (3.27–10.09), P < 0.001). There was no significant
relationship found between reduced bone density and subcutaneous adipose tissue thickness or mesenteric adipose tissue ratio (P =
0.073, P = 0.939, respectively).
Conclusion: In the geriatric age group, reduced bone density and muscle atrophy were quite common and were significantly more
frequent in women. Furthermore, a strong association between reduced bone density and muscle atrophy was found. No relationship
was found between reduced bone density and subcutaneous adipose tissue thickness–mesenteric adipose ratio.
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1. Introduction
In the geriatric age group, advancing age and decreased
activity lead to bone and muscle loss. Age-related bone
loss is also dependent on hormonal effects such as changes
in sex-steroid hormones, vitamin D, and parathyroid
hormone levels (1). Chronic disease and some drugs
also play an important role in the pathophysiology of the
osteoporosis (2). Along with aging, osteoblast formation
decreases whereas lipid storage in the bone marrow
increases (1). The pathophysiology of osteoporosis in
men has been a popular research topic in recent years.
Although male osteoporosis is underrecognized and
undertreated, it is considered to be an increasing health
problem (3,4). Progressive loss of muscle mass starts
around the age of 40 (5). With menopause, muscle mass
is reduced by 3% per year, with up to 30%–50% of loss
between 40 and 80 years of age (5). Sarcopenia occurs with
a loss in muscle mass and muscle strength. Dual-energy
X-ray absorptiometry (DXA) and CT are widely used for

the diagnosis of osteoporosis and sarcopenia. Paraspinal,
psoas, and abdominal wall muscle areas are evaluated in
a single transverse cross-section at the L3 level on CT in
various studies to diagnosis muscle atrophy (6,7).
The aim of this study was to determine the frequency
of reduced bone density in a geriatric patient group with
preexisting abdominal CT examinations and to reveal the
relationship between adipose tissue and muscle atrophy.
2. Materials and methods
This is a retrospective cohort study. Ethics committee
approval was obtained for the study. All patients aged
65 years and over who underwent abdominal CT for
any reason between October 2017 and July 2018 were
sequentially included in the study.
Patients who were diagnosed with an intraabdominal
mass, intraabdominal widespread free fluid, ileus, vertebral
tumor, vertebral fracture, or large herniation on the
anterior wall of the abdomen were excluded from the study.
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A total of 312 patients were included in the study.
Retrospectively, our patients were reviewed for chronic
diseases using the hospital electronic medical record
system. A total of 117 of the 312 patients had significant
findings in terms of bone and metabolic diseases: 37 cases
of diabetes mellitus (DM), 48 cases of hypertension, 15
cases of DM + hypertension, 9 cases of osteoporosis, 18
cases of asthma, 7 cases of anemia, 11 cases of vitamin
D deficiency, 14 cases of hypothyroidism, and 16 cases
of depression were found with clinical and laboratory
assessments.
For all shots, 128-slice CT (Optima CT660, GE
Healthcare, Chicago, IL, USA) was used. Parameters
used for abdominal CT were slice thickness of
3 mm, average 120–130 kV, and 100–130 mAs.
All measurements were made on transverse images
through the third lumbar vertebra’s (L3) center, using a
single oval click-and-drag region of interest (ROI). The
vertebral density measurement was performed from the
L3 vertebral trabecular region, and the cortex was not
included in the measurement area (Figure 1). Average
ROI width was 1.5 cm2. Hounsfield unit (HU) values
were recorded for each vertebra. The posterior venous
plexus, focal vertebral lesions such as hemangiomas,
and artifact areas that could affect the value during ROI
measurement were avoided. Values of less than 120 HU on
the L3 vertebral measurement were accepted as signifying
reduced bone density (RBD).
Muscle atrophy based on visual appearance and
HU value of the muscle were evaluated in the psoas and
posterior paravertebral muscles (Figure 2). Following
Swash et al. (8), atrophy was graded as follows: Grade
0 (normal); Grade 1 (atrophic), a muscle of reduced
area, and/or decreased attenuation; Grade 2, a muscle
containing multiple patchy areas of low attenuation; Grade
3, a muscle of generally low attenuation. We considered
Grades 1, 2, and 3 to be muscle atrophy and Grade 0 to
be normal muscle in our study (8). Garay Mora et al. (9)
indicated that less than 30 HU density indicated atrophy
in any muscle. In addition to visual assessment (8), muscle
density values below 30 HU were recorded as muscle
atrophy in our study (9).
In transverse sections passing through the umbilicus,
subcutaneous fat tissue thickness (SCF) was measured
from the right side of the umbilicus (Figure 3). In the
same section, the mesenteric fat tissue thickness ratio
(MFR) was assessed as the ratio of intraabdominal fat
tissue thickness (from the anterior wall of the aorta to the
anterior wall of the abdomen) of the complete anterior–
posterior abdominal diameter from skin to skin (Figure 4).
2.1. Statistical analysis
Data were tested for normality using the single-sample
Kolmogorov–Smirnov test, histogram, Q–Q plots, and
box plot graphs. Data are presented as mean, standard

Figure 1. The vertebral density measurement is shown on a
transverse CT image. 148 HU, normal vertebral density.

Figure 2. Muscle atrophy is evaluated visually using ROI on the
CT image; according to visual evaluation, Grade 0 (normal),
and muscle density measurement is 55 HU, which is recorded as
normal muscle mass.

deviation, median, minimum, maximum, frequency,
and percentage. For the variables with 2 categories (sex
and osteoporosis), normally distributed variables were
analyzed with an independent-samples t-test, and variables
with nonnormal distribution were analyzed with the
Mann–Whitney U test. Nominal variables were assessed
with the chi-square test. Odds ratio (OR) values and 95%
CI were calculated. P < 0.05 was considered significant,
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Figure 3. In transverse sections passing through the umbilicus,
subcutaneous fat tissue thickness (SCF) was measured from the
right side of the umbilicus.

and this significance was calculated bidirectionally. All
analyses were performed using the NCSS 10 software
program (Kaysville, UT, USA).
3. Results
A total of 312 patients, 144 females and 168 males, at the
age of 65 or above were included in the study. The mean age
of all patients was found to be 73.43 ± 7.15 (min–max: 65–
95). Mean age was 70 (min–max: 65–95) for females and 72
(min–max: 65–90) for males. Age distribution was found
to be homogeneous (P = 0.594, Mann–Whitney U test).
RBD was detected in 237 (76%) of 312 patients, while
paravertebral muscle atrophy (PVMA) was detected in 197
(63%) patients. The mean subcutaneous fat tissue thickness
in all patients was found to be 19 mm (min–max: 3–90).
In terms of RBD, the mean L3 vertebrae density in
females was 86 HU (26–169) and it was 104 HU (18–191)
in males. RBD was found in 128 of 144 female patients
(88.9%), while it was found in only 109 of 168 (64.9%)
male patients. RBD was found 4.33 times more frequently
in women (OR, 95% CI = 4.33 (2.36–7.9), P < 0.001,
Pearson’s chi-square test).

Figure 4. The mesenteric fat tissue thickness ratio was assessed
as follows: the ratio of intraabdominal fat tissue thickness (from
the anterior wall of aorta to the anterior wall of abdomen) of the
entire anterior–posterior abdominal diameter from skin to skin.

In terms of muscular atrophy, PVMA was found in
112 female patients (77.8%), but in only 85 of 168 male
patients (50.6%). PVMA was found to be 3.4 times more
frequent in women (OR, 95% CI = 3.4 (2.08–5.62), P <
0.001, Pearson’s chi-square test).
In terms of subcutaneous fat tissue, mean thickness
was 25 (3–90) mm in female and 15.5 (3–34) mm in male
patients. Subcutaneous fat tissue thickness was higher in
females than in males (P < 0.001).
Mean mesenteric fat tissue ratio was 0.33 ± 0.075
in females and 0.34 ± 0.075 in males. There was no sex
difference found for MFR (P = 0.196).
Reduced bone density, spinal muscular atrophy,
subcutaneous fat thickness, and visceral fat ratio
distribution in geriatric patients are given in the Table.
In the assessment of RBD–muscle atrophy association,
PVMA was detected in 173 patients (73%) with RBD (n
= 237). On the other hand, PVMA was detected in 24
patients (32%) with normal bone density (n = 75). Muscle
atrophy was 5.7 times more frequent in RBD (OR, 95% CI
= 5.74 (3.27–10.09), P < 0.001, Pearson’s chi-square test).

Table. Distribution of reduced bone density, spinal muscular atrophy, subcutaneous fat thickness, and visceral fat ratio in geriatric
patients (Mann–Whitney U test, Pearson chi-square test).
Age

Reduced bone
density

Spinal muscular
atrophy

Subcutaneous fat
thickness

Visceral fat ratio

Female (n = 144)

70 (65–95)

88.9% (n = 128)

77.8% (n = 112)

25 (3–90) mm

0.33 ± 0.075

Male (n = 168)

72 (65–90)

64.9% (n = 109)

50.6% (n = 85)

15.5 (3–34) mm

0.34 ± 0.075

P-value

P = 0.594

P < 0.001

P < 0.001

P < 0.001

P = 0.196
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In the assessment of RBD–subcutaneous fat tissue
association, SCF was measured as 20 (3–90) mm in patients
with RBD and 16 (4–44) mm in patients with normal bone
density. No significant difference was found between the
subcutaneous fat tissue thickness of RBD patients and that
of patients with normal bone density (P = 0.073, Mann–
Whitney U test).
In the assessment of RBD–MFR association, MFR
was 0.34 ± 0.074 in patients with RBD and 0.34 ± 0.08
in patients with normal bone density. There was no
significant relationship between RBD and MFR (P = 0.939,
independent-samples t-test).
4. Discussion
The highlights of our study are as follows: RBD was detected
in 237 (76%) of 312 geriatric patients and was 4.33 times
more frequent in female patients (OR, 95% CI = 4.33 (2.36–
7.9), P < 0.001). On the other hand, RBD affected more than
half of the males in the geriatric population. In 312 geriatric
patients, PVMA was detected in 197 patients (63%) and
was 3.4 times more frequent in females (OR, 95% CI = 3.4
(2.08–5.62), P < 0.001). Muscle atrophy was 5.7 times more
frequent in RBD patients (OR, 95% CI = 5.74 (3.27–10.09),
P < 0.001). There was a strong association between RBD and
muscle atrophy in our study. Sarcopenia and osteoporosis
have been closely linked in the recent literature, especially
affecting the geriatric age group. Osteosarcopenia is a new
terminology used for the diagnosis of both osteoporosis
and sarcopenia in older patients (10). In our study, RBD
and muscle atrophy detected on CT may not fully meet
the definition of osteosarcopenia. On the other hand, the
risk of osteosarcopenia can be determined with a simple
evaluation of the preexisting CT and further examination
may be recommended. Murray et al. (11) indicated that it is
possible to diagnose osteoporosis, obesity, and sarcopenia
on abdominal CT, and that diagnosing these is beneficial
to the patient.
DXA is routinely used for the diagnosis of osteoporosis
affected by degenerative changes. This study shows a
significant limitation of DXA (12,13). Surgical clips, barium
sulfate, other metal objects, osteophytes, syndesmophytes,
compression fractures, and aortic calcification falsely
elevate BMD (14). Marinova et al. (15) reported that
vertebral density measurement on CT was sensitive in
terms of detecting osteoporosis and superior to DXA. Li
et al. (16) recommended that radiologists examine and
report osteoporosis on routine abdominal CT. In addition,
Zaidi et al. (17)noted that HU value measurement is a
useful and practical technique for assessing bone quality
that could be reported by a radiologist in all patients with
preexisting abdominal CT scans. Pickhardt et al. (18), in
their comprehensive series using CT and DXA, determined
that their threshold values for osteoporosis at vertebrae
L1 to T12 ranged from 110 to 120 HU, whereas normal

vertebral density was determined as 200 HU or higher.
Values over 200 HU are reported to be accepted as normal
and not requiring DXA (18). According to those studies, we
evaluated values below 120 HU at the L3 vertebra level as
osteopenia/osteoporosis (reduced bone density = RBD). In
our study, the diagnosis of muscle atrophy on CT was based
on the measurement of density (8) and visual assessment
(9) of the psoas and paraspinal muscles at L3 level.
There have been various studies examining the
association between osteoporosis and adipose tissue in the
literature. It has been reported that there is a mechanism
increasing adipogenesis in stem cell physiology and
reducing osteoblastogenesis and bone formation with
increasing age (1). Another common hypothesis is that
adipose tissue and obesity function as physical barriers and
induce osteoblastogenesis and increase bone formation
(19–21). It has been reported that android type obesity
with visceral predominance has more risks than gynoid
type obesity with subcutaneous predominance (22).
Measurement of subcutaneous fat tissue and mesenteric fat
tissue at the L3 level using additional software during the CT
scan can be found in the literature (23–25). We measured
the paraumbilical subcutaneous fat tissue thickness and
MFR at the L3 level; subcutaneous fat tissue thickness was
found to be higher in females than in males (P < 0.001).
Subcutaneous fat tissue thickness was not significantly
different between patients with and without reduced bone
density (P = 0.073, Mann–Whitney test). There was no
significant relationship between bone density and MFR (P
= 0.939). In our study, there was no significant relationship
found between reduced bone density, subcutaneous fat
tissue, and mesenteric fat tissue, suggesting that visceral
lipidosis may not be a risk factor for reduced bone density.
As a limitation of this study, in terms of nonvolumetric
examination, we may have failed to determine the actual
increase in visceral lipidosis with the practical measurement
method. With mesenteric fat tissue measurement, we tried
to implement an easy-to-use method that can be applied
during preexisting CT evaluation and does not require
additional cost or time. It is recommended that this method
be compared with volumetric measurement of fat tissue in
CT with a new study. Another limitation is that body mass
index was unknown for the patients in this retrospective
study.
In conclusion, our results demonstrated that reduced
bone density and muscle atrophy were frequently seen
in the geriatric population, significantly more frequently
in women. Furthermore, a strong association was found
between reduced bone density and muscle atrophy. No
relationship was found between reduced bone density and
subcutaneous fat tissue thickness–mesenteric adipose ratio.
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